Peptide Knowledge Base · Longevity
Pinealon: what it is, what the evidence says, and its real status
A short 'bioregulator' peptide from the Russian Khavinson school, claimed for brain and longevity support, thin Western validation.
Short version: a Khavinson-school 'bioregulator' with bold Russian-origin claims and thin independent validation. Long-tail, podcast-driven, education only.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: Research-only · Education only.
Not offered, education only. Pinealon is a Khavinson-class peptide with Russian-origin claims and limited independent Western validation. Not FDA-approved, not available; we capture the query and say what we don't know.
How does Pinealon work?
A tripeptide proposed by the Khavinson school to act as a tissue-specific 'bioregulator' of neuronal gene expression.
What it does — and what it does not do
What it does: Claimed in Russian-origin work to support cognition and cellular aging.
What it does not do: It is not independently validated, not approved, and not available.
How honest is the evidence?
Evidence grade D — Russian-origin claims; thin independent replication. Read our grading methodology for what each grade means.
What we still don't know: Independent Western replication is scarce; mechanism and outcomes are unconfirmed.
WADA status: Not prohibited.
How it is taken
No established human clinical dosing; research-stage.
Who should not take it
Not characterized in independent practice; no established safety profile.
Sources
Khavinson peptide-bioregulator literature (limited independent replication)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.